Corporate Corruption Media Articles

Excerpts of Key Corporate Corruption Media Articles in Major Media

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Nine years ago, the state of Florida received documentation from a security firm vouching for the mental health of Omar Mateen, who launched a bloody attack this week on Orlando nightclub patrons. But the psychologist whose name appears on the document in state records said Friday that she never evaluated [Mateen]. In fact, she wasn’t even living in Florida when the evaluation was supposedly completed. The revelation Friday became another source of scrutiny for the G4S security firm, which was known as Wackenhut at the time. The psychological evaluation done for the company, which is required under state law, cleared Mateen to carry a firearm as a private security guard. “What I do know is that in September 2007, I was not living or working in Florida, I was not performing any work for Wackenhut, and I did not administer any type of examination to Omar Mateen,” Dr. Carol Nudelman, who now lives in Colorado, said in a statement. The global security firm - which does work in more than 100 countries - is locally based in Jupiter. Its operations have come under scrutiny a number of times over the years. In the mid-2000s, G4S was accused of overbilling Miami-Dade County taxpayers of at least $3 million for security services that were not actually provided. But a criminal case against company employees fizzled in 2012.

Note: A CBS News story titled, "Locked Inside a Nightmare" sheds light on Wackenhut's profoundly corrupt history. For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

A delegation of independent scientists urged the EPA to ban RoundUp, Monsanto’s flagship herbicide. Providing testimony that it poses an unreasonable risk to humans, animals, and the environment, scientists spoke at a closed meeting with EPA [officials]. The scientists explained the physiological reasons why exposure to glyphosate, the active ingredient in RoundUp, is linked to autism, Alzheimer’s, cancer, birth defects, obesity, gluten intolerance, among other health issues. 300 million pounds of RoundUp are sprayed each year on corn, soy, sugar beets, canola, and weeds in the United States alone. $5 billion, or half Monsanto’s annual sales, comes from glyphosate-containing products. Dr. Stephen Frantz, Pathobiologist Research Scientist led the team. “When a cell is trying to form proteins, it may grab glyphosate instead of glycine to form a damaged, mis-folded protein. After that it’s medical chaos ... with many diseases and disorders as a result.” Moms Across America founder Zen Honeycutt was a participant at the meeting. Her son had been a casualty of processed foods, diagnosed with autism until his mother switched to an all-organic diet. “Mothers and caretakers are seeing their loved ones get sick on GMOs and glyphosate/herbicide sprayed foods and get better when they avoid them. Because glyphosate is contaminating our urine, water, breast milk and nearly all our foods, we are systematically causing sickness throughout America.”

Note: The negative health impacts of Monsanto's Roundup are well known. Lawsuits are building over Monsanto's lies to regulators and the public about the safety of glyphosate. Yet the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

The security firm that employed Orlando shooter Omar Mateen concluded that allegations about his inflammatory comments while an armed guard in 2013 were serious enough to transfer him to an unarmed position. But the company, G4S Secure Solutions USA Inc., dropped the matter [and] did not take away his company-issued service weapon. That decision, coupled with the fact that Mateen underwent three separate inquiries by the FBI in 2013 and 2014, raises questions about whether G4S - the U.S. subsidiary of one of the world's largest security firms - properly vetted Mateen in the years before Sunday's mass shooting at the Pulse nightclub. Former G4S security guard Daniel Gilroy ... complained repeatedly about Mateen to supervisors at G4S. They ignored his concerns. Ultimately, Gilroy said, he quit rather than have to face Mateen, who he said threatened him. [A company official] said G4S has so far found no evidence of any other employees making complaints about Mateen, including those who worked at the St. Lucie County Courthouse with him in 2013. FBI Director James Comey said earlier this week that colleagues said Mateen claimed to have family connections to terror groups al Qaeda and Hezbollah, and that he hoped law enforcement would raid his home "so he could martyr himself." Those remarks prompted courthouse officials to request Mateen's immediate removal from the St. Lucie County Courthouse, and to make "the appropriate notifications to inform our federal partners," including the FBI.

Note: For more along these lines, see concise summaries of deeply revealing news articles about corporate corruption and terrorism.

In April, the email in-boxes of energy executives filled with alerts from the nation’s top corporate law firms. The subject: the multistate investigation into whether Exxon Mobil committed fraud by publicly discounting the impact of fossil fuels on climate change. The investigations into whether their industry suppressed findings and misled investors, policymakers and the public about global warming not only raise the prospects of criminal charges, but add momentum to a legal campaign [comparable] to the decades-long battle against Big Tobacco. In April, a federal judge in Oregon ruled that a case against the U.S. government for inaction on climate change could proceed, explaining that “the alleged valuing of short term economic interest despite the cost to human life” required examination by the courts. Environmental lawyers have argued for years that governments and companies are legally obligated to reduce greenhouse gas emissions. They had little success, with the U.S. Supreme Court ruling in 2011 that the federal government alone had the power to control carbon emissions. But the recent entry of state prosecutors into the legal battle opens up a new line of inquiry: Did fossil fuel companies mislead their investors and the public on their own views on climate change and the risk it posed to their business? The recent legal rush follows the revelation last year that Exxon had engaged in climate change research in the 1970s and ’80s, and was warned by its own scientists of the growing threat.

Note: Read about the recent New York Attorney General's investigation into Exxon's climate change lies. For more along these lines, see concise summaries of deeply revealing climate change news articles from reliable major media sources.

Atrazine [is] the second most commonly used herbicide in the United States. [It] is mainly used to control weeds in the corn blanketing much of the Midwest. The chemical also routinely turns up in streams and drinking water. And according to a new Environmental Protection Agency preliminary risk assessment, it may be doing serious harm to fish, animals, and amphibians, even at extremely low exposure levels. In the areas where it is most commonly used, mainly the Midwestern corn belt, atrazine turns up in the environment at rates that exceed established levels of concern "by as much as 22, 198, and 62 times for birds, mammals, and fish, respectively," the report concluded. The European Union banned atrazine in 2004, citing its potential to contaminate water and harm ecosystems. And this latest EPA report suggests the US government might also consider reining in use of the chemical. But probably not anytime soon. Back in 2011, the EPA released the final deliberations by a panel of independent scientists it had convened to address the topic. The panel found that atrazine had "suggestive evidence of carcinogenic potential" for ovarian cancer, non-Hodgkin's lymphoma, hairy-cell leukemia, and thyroid cancer. A recent paper by Texas A&M and Iowa State University researchers looked at research published since 2000 and concluded that "higher concentrations of atrazine in drinking water" have been associated with a variety of birth defects in people.

Note: With US regulators in its pocket, agrichemical giant Syngenta did everything in its power to discredit atrazine researcher Tyrone Hayes after Hayes published science proving that Syngenta's products were poisonous. The New Yorker published a detailed article on Syngenta's smear campaign. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health.

Genentech and another drugmaker will pay $67 million to settle claims that they misled doctors into prescribing a treatment to lung cancer patients for whom the companies knew it would not work. As a result, some patients may have died earlier than they would have if they had taken more effective drugs, a lawsuit brought by a former Genentech employee and joined by federal prosecutors alleges. From 2006 to 2011 Genentech and its marketing partner OSI Pharmaceuticals promoted Tarceva to treat all patients with non-small-cell lung cancer even though studies had shown that it worked for just those who had never smoked or had a certain gene mutation known as EGFR. Epidermal growth factor receptor is a type of protein found on the surface of cells in the body. The whistle-blower lawsuit was filed in 2011 by Brian Shields, who worked as a Tarceva sales representative and then a product manager. The lawsuit said the companies ... discouraged doctors from testing patients for EGFR. The companies also promoted Tarceva ... by giving doctors illegal kickbacks disguised as fees for making speeches or serving on Genentech’s advisory boards. Sales representatives across the country were “instructed to spend lavishly” on physicians, the case said, and given “an unlimited budget to wine and dine.” Genentech also organized lunches or dinners for lung cancer patients where “patient ambassadors” were paid fees to speak about how Tarceva could be used in ways never approved by regulators, the lawsuit said.

Note: While Genentech was inaccurately describing its new drugs to doctors and patients, this company was also fiercely lobbying to prevent others from selling affordable alternatives to its costly drugs. Practices like this, along with the suppression of promising cancer research, show how Big Pharma puts profit before people.

Prime ministers, finance ministers, leading entrepreneurs and a former spy chief are among the attendees at this year’s influential Bilderberg conference ... which begins on Thursday in Dresden. The German military has been drafted in to oversee security. They’re working with corporate security from Airbus to make sure the politicians are kept safely away from the press for the entire three-day conference. Every year, a major corporation with links to the Bilderberg steering committee coordinates security for the event with the police. Which makes the whole conference even more obviously the corporate lobbying event that it is - with giant corporations handling everything from security to dry ice. And it makes the silence of the politicians who attend even more egregious. These high-level talks between policymakers and the heads of transnational oil companies ... take place in heavily guarded privacy, with no press oversight whatsoever. [This is] especially great if you’re on the board of BP. Like, for example, Sir John Sawers. As well as being a director of BP, the silken, Blairish former MI6 boss is a member of Bilderberg’s steering committee, and the chairman of Macro Advisory Partners, a global advisory group with heavy links to the transatlantic intelligence community, very much in the style of Kissinger Associates. And speak of the devil! The ageless 93-year-old former US secretary of state will be holding court at Dresden, croaking out his wisdom from the throne of bones he has shipped everywhere he goes.

Note: This entire article is a must read if you want to know how the power elite work together to manipulate global politics. For more along these lines, see concise summaries of deeply revealing news articles on the Bilderberg Group and other elite secret societies.

More than a decade ago, researchers at Gilead Sciences thought they had a breakthrough: a new version of the company’s key HIV medicine that was less toxic to kidneys and bones. Clinical trials ... seemed to support their optimism. Patients needed just a fraction of the dose, creating the chance of far fewer dangerous side effects. But in 2004 ... Gilead executives stopped the research. The results of the early patient studies would go unpublished for years as the original medication - tenofovir - became one of the world’s most-prescribed drugs for HIV, with $11 billion in annual sales. In 2010, Gilead restarted those trials. A year of treatment with Gilead’s HIV medicines costs about $30,000. Earlier this year, the Los Angeles-based AIDS Healthcare Foundation, which operates clinics and pharmacies for AIDS patients, sued Gilead, contending that it delayed the less toxic form of tenofovir to manipulate the patent system and keep prices artificially high. Animal studies showed that [tenofovir] could cause damage to the kidneys and bones. When the drug was approved in 2001, the FDA required Gilead to study whether the medicine would harm humans in the same way. [By] 2003, the company had received so many reports of patients experiencing kidney failure and other ... problems that it placed a warning on the drug’s label. Several times, U.S. regulators formally warned Gilead that it was downplaying the drug’s risks.

Note: After the FDA warned Gilead that its sales reps were illegally lying to doctors about tenofovir's safety, Gilead continued misrepresenting this drug, prompting the FDC to send the company a rare second warning letter. For more along these lines, see concise summaries of deeply revealing big Pharma profiteering news articles from reliable major media sources.

Corey Feldman, who has opened up in the past about being molested by multiple Hollywood bigwigs, said he believes the problem of producer pedophiles is bigger today in age of social media. He’s also said one of his abusers is “still prominently in the business today.” Gabe Hoffman is the executive producer of “An Open Secret,” a 2015 documentary that investigated child molesters in Hollywood, and he echoed Feldman’s sentiments. "Young people, both boys and girls looking to work in Hollywood are at great risk from sexual predators,” he [said]. Psychologist Dr. Judith Zackson concurred. “The Internet is becoming an increasingly dangerous place for young, vulnerable stars,” she said. “Internet profiles provide an anonymous platform for pedophiles to study their victim’s personal information and patterns to assist in their ‘grooming’ process - pedophiles develop a relationship with their victims through enticing dialogue filled with promises that promote the young stars dream.” Pop culture expert Cate Meighan said the Internet lets abusers reach out to victims more easily. “Back in the ‘80s it really was quite different in that these people had to wait until child stars were brought into their circle to have access to them,” she said. “Now, they have the ability to hand pick potential targets and probably at a much younger age too.” Feldman has been vocal in the past regarding pedophilia in Hollywood. In 2011, he said it was “the number one problem in Hollywood” claiming it to be “the big secret” plaguing the industry.

Note: Don't miss the incredible film "An Open Secret" which follows five boys and their families who were gradually ensnared by a secret Hollywood pedophile ring which ruins their lives. It is available for free viewing on this webpage. The entire "Secret Societies in Hollywood" series is available here. For more along these lines, see concise summaries of deeply revealing sexual abuse scandal news articles from reliable major media sources.

Elijah Wood called out child exploitation in Hollywood earlier this week. He later made it clear that he was not speaking from personal experience. But Corey Feldman wants people to know that he knows about Hollywood's child abuse problem firsthand. In an interview with the Hollywood Reporter, Feldman said he was molested as a child actor, and that his best friend Corey Haim was raped at the age of 11. He said that he has had to go through "a lot of therapy" to cope with his traumatic childhood; the actor said his molestations came "from several hands." "Ask anybody in our group of kids at that time: They were passing us back and forth to each other," said Feldman, adding that grown men in Hollywood would host parties and invite mostly kids aged 10 to 16 with just a few adults in the mix. "[Alison Arngrim] from 'Little House on the Prairie' said [in an interview], 'Everybody knew that the two Coreys were just being passed around.' Like it was something people joked about on studio lots." Feldman added that he still can't imagine what it was like for Haim to have been raped. "My son is 11 now, and I can't even begin to fathom the idea of something like that happening to him," he said. Feldman said that while he would love to name names, he was afraid to do so because of the legal conundrum it would inflict on him, but he said he has bumped into one of his molesters several times and has never confronted him.

Note: Don't miss the incredible film "An Open Secret" which follows five boys and their families who were gradually ensnared by a secret Hollywood pedophile ring which ruins their lives. It is available for free viewing on this webpage. The entire "Secret Societies in Hollywood" series is available here. For more along these lines, see concise summaries of deeply revealing sexual abuse scandal news articles from reliable major media sources.

CEOs at the biggest companies got a 4.5 percent pay raise last year. That's almost double the typical American worker's, and a lot more than investors earned from owning their stocks - a big fat zero. The typical chief executive in the Standard & Poor's 500 index made $10.8 million, including bonuses, stock awards and other compensation, according to a study by executive data firm Equilar for The Associated Press. That's up from the median of $10.3 million the same group of CEOs made a year earlier. The raise alone for median CEO pay last year, $468,449, is more than 10 times what the typical U.S. worker makes in a year. The median full-time worker earned $809 weekly in 2015, up from $791 in 2014. "With inflation running at less than 2 percent, why?" asks Charles Elson, director of the John L. Weinberg Center for Corporate Governance at the University of Delaware. The answer is complicated. CEO pay packages now hinge on multiple layers of sometimes esoteric measurements of performance. That's a result of corporate boards attempting to respond to years of criticism ... from Main Street America, regulators and even candidates on the presidential trail this year. One bright spot, experts say, is the rise in the number of companies that tie CEO pay to how well their stocks perform. "There's progress generally in aligning compensation with shareholder returns," says Stu Dalheim, vice president of governance and advocacy at Calvert Investments. "But I don't think this compensation is sustainable."

Note: For more along these lines, see concise summaries of deeply revealing income inequality news articles from reliable major media sources.

Brazil’s suspended president has described the impeachment campaign as "more clearly than ever" a "coup" after leaked tapes suggested that her opponents were trying to remove her simply to halt a corruption probe. In only her second public appearance since being removed from office pending a trial, Dilma Rousseff responded to new evidence suggesting that the aim of the impeachment process is stifle a massive corruption inquiry, known as the “Car Wash” probe. Leaked tapes appear to show Romero Jucá, the planning minister in the new government, discussing the impeachment process as a way of stopping the “Car Wash” inquiry into corruption at Petrobras, the state oil company ... which has implicated dozens of politicians. In the conversation, Mr Jucá appears to agree that “there has to be an impeachment” to halt the probe. Mr Jucá has also been suspended from office. The revelations boosted Ms Rousseff’s Workers’ Party, or “PT”, which has repeatedly described the campaign to oust her as a “coup”. Ricardo Berzoini, a senior member of Ms Rousseff’s cabinet, said the “revelation” of the tapes “demonstrates the real reason for the coup against democracy.” Mr Berzoini added: “The goal is to stop the Car Wash investigation and sweep the investigation under the rug. The Brazilian people have a right to know everything about these recordings. We cannot allow a dialogue like this to not be investigated thoroughly.”

Note: This coup is reportedly handing literal control of Brazil's economy to Goldman Sachs and bank industry lobbyists. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the corporate world.

Environmentalists have taken to streets around the world to protest against seed giant Monsanto at the same time as the company is facing a $62 billion takeover by Bayer, the German drugs giant. More than 400 simultaneous demonstrations against genetically modified crops and pesticides were organised around the world this weekend. The protests took place in over 40 countries. They come come as Monsanto faces an unsolicited takeover offer by Bayer, the chemical giant that invented aspirin. The deal could create the world’s biggest supplier of farm chemical and genetically modified seeds. Up to 3,000 protesters, rallied by environmental organisations including Greenpeace and Stop TAFTA, an anti-capitalist group, gathered in Paris, according to Agence France Presse. Protesters voiced their anger against Monsanto’s herbicide Roundup which is classified as “probably carcinogenic to humans” by the World Health Organisation. In the US, where 90 per cent of corn, soybean and cotton is genetically modified, campaigners promoted the march with a billboard in Times Square, showing a topless model and the slogan: “Keep GMOs out of your genes.” On Monday Bayer made an unsolicited $62 billion all-cash offer to acquire Monsanto. A concentration of corporate power in the agriculture and chemical sector would be bad news for both farmers and consumers. It would accelerate the decrease in crop diversity while limiting consumer choice. Farmers would ... find it harder to choose what they grow and how they grow it.

Note: Bayer's pesticides have been implicated in the collapse of bee populations. Glyphosate, the main ingredient in Monsanto's "RoundUp" pesticide, is now the most heavily-used agricultural chemical ever and probably causes cancer. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

When the price of the blood-pressure drug Nitropress leaped from $215 to $881 last year, an increase of 300%, it triggered public outrage. [Drug maker] Valeant Pharmaceuticals International ... would buy patents for unique, lifesaving drugs, hike their prices and then watch the profits roll in. In the wake of the Valeant pricing scandal ... congressional and media investigations have revealed that the embattled company’s business model is hardly unique. In a memo from Oct. 16, 2015 ... the global investment bank Canaccord Genuity wrote that the price increases were not out of the ordinary. In a report from the same day, BMO Capital Markets reiterated that Valeant’s tactics were a “common industry practice” and that “at least 14 different pharmaceutical companies, excluding Valeant,” had made similar price hikes in recent years. The drug industry boasts some of the biggest profits of any industry. Wall Street investors have swooned over the sector. From 2012 to the middle of 2015, more than $50 billion in new capital poured into the industry. That influx of cash shifted the character of the industry. Instead of focusing on time-consuming R&D, drug companies began worrying more about delivering short-term gains to shareholders. For 20 of the biggest drug companies, 80% of shareholder earnings in 2014 were the result of price hikes. [The] industry ... spends more on lobbying than any other industry in the country.

Note: For more along these lines, see concise summaries of deeply revealing big Pharma profiteering news articles from reliable major media sources.

In August 2015, Turing Pharmaceuticals and its then-chief executive, Martin Shkreli, purchased a drug called Daraprim and immediately raised its price more than 5,000 percent. Within days, Turing contacted ... PSI, a charity that helps people meet the insurance copayments on costly drugs. Turing wanted PSI to create a fund for patients with toxoplasmosis, a parasitic infection that is most often treated with Daraprim. Having just made Daraprim much more costly, Turing was now offering to make it more affordable. But this is not a feel-good story. It’s a story about why expensive drugs keep getting more expensive, and how U.S. taxpayers support a billion-dollar system in which charitable giving is, in effect, a very profitable form of investing for drug companies - one that may also be tax-deductible. PSI, which runs similar programs for more than 20 diseases, jumped at Turing’s offer. PSI is a patient-assistance charitable organization, commonly known as a copay charity. It’s one of seven large charities ... offering assistance to some of the 40 million Americans covered through the government-funded Medicare drug program. A million-dollar contribution from a pharmaceutical company to a copay charity can keep hundreds of patients from abandoning a newly pricey drug. Fueled almost entirely by drugmakers’ contributions, the seven biggest copay charities, which cover scores of diseases, had combined contributions of $1.1 billion in 2014. For that $1 billion in aid, drug companies “get many billions back” from insurers.

Note: For more along these lines, see concise summaries of deeply revealing pharmaceutical industry corruption news articles from reliable major media sources.

Would you read a story if this was the headline: "New study raises questions about an experimental treatment that might not work and won't be ready for a long time." That description would apply to most medical studies that make the news but would be unlikely to generate the clicks, taps, likes and shares that propel a story through cyberspace and social media. What gets clicks? Words like "breakthrough," "groundbreaking," "game changer" and "lifesaver." Since the 1970s, the use of positive words in scientific abstracts increased by 880 per cent, according to a study last December in the British Medical Journal. And now, the world's stem cell scientists have been told to stop the hype. The International Society for Stem Cell Research (ISSCR) issued new guidelines last week that urge scientists to dial back their enthusiasm when talking publicly about their research. Because people are getting hurt. Last December, the Food and Drug Administration in the U.S. issued a warning letter to a U.S.-based company offering stem cell therapies for a range of diseases, including autism, multiple sclerosis and Parkinson's disease. And a U.K. newspaper claims its undercover investigation lead to the closure of a controversial clinic in Germany where a child died after having stem cells injected into his brain. "There is ... an industry already out there that is marketing unproven therapies directly to patients," said George Daley, a member of the ISSCR and a professor at Harvard Medical School. "It is part of the concern that has raised the alarm."

Note: According to Richard Horton, chief editor of The Lancet, up to half of all science journal claims may be untrue. Read also the revealing comments of Marcia Angell, former editor-in-chief of the New England Journal of Medicine, on the massive corruption she found in the health industry. For more along these lines, see concise summaries of deeply revealing science corruption news articles from reliable major media sources.

Say the name Bernie Madoff, and chances are everyone will immediately remember the Ponzi scheme that bilked investors of $64 billion. What likely won’t spring to mind is JPMorgan Chase’s role in the more than decadelong fraud. And the link is all the more egregious, Helen Davis Chaitman, an attorney who represents 1,600 of Madoff’s victims, and Lance Gotthoffer write in “JPMadoff: The Unholy Alliance Between America’s Biggest Bank and America’s Biggest Crook,” because the federal government has failed to prosecute any of the bankers involved. Madoff trustee Irving Picard laid out JPMorgan’s involvement in a complaint, which was turned into a list of stipulations the government entered as part of a deferred prosecution agreement with JPMorgan. The stipulations outline two violations of the Bank Secrecy Act, under which banks are responsible for alerting authorities to suspected illegal activity by customers. JPMorgan, the world’s sixth-largest bank by total assets, pleaded ignorance of wrongdoing but accepted the stipulations and paid a $1.7 billion fine. [When] Madoff began kiting checks ... Bankers Trust Co. spotted the illegal activity and closed Madoff’s account. That’s when Madoff moved his business to JPMorgan, depositing $150 billion from 1986 through 2008. JPMorgan handled only Madoff’s illegal investment advisory business, not the successful stock trading business that employed 190 of Madoff’s 200 employees. And though the bank was prosecuted, none of the bankers involved with Madoff’s account were.

Note: JP Morgan Chase's role in the Madoff scandal is outrageous, but it is relatively minor in comparison to the massive securities fraud and cover-up perpetrated by this and other corrupt financial institutions.

I’m a science journalist. That keeps me busy, because, as you know, most peer-reviewed scientific claims are wrong. So I’m a skeptic, but with a small s, not capital S. “The Science Delusion” is common among Capital-S Skeptics. You don’t apply your skepticism equally. You are extremely critical of belief in God, ghosts, heaven, ESP, astrology, homeopathy and Bigfoot. Meanwhile, you neglect [many] dubious and even harmful claims promoted by major scientists and institutions. Let’s take a look at ... mainstream medicine. Over the past half-century, physicians and hospitals have introduced increasingly sophisticated, expensive tests. They assure us that early detection of disease will lead to better health. But tests often do more harm than good. For every woman whose life is extended because a mammogram detected a tumor, up to 33 receive unnecessary treatment, including biopsies, surgery, radiation and chemotherapy. For men diagnosed with prostate cancer after a PSA test, the ratio is 47 to one. Similar data are emerging on colonoscopies and other tests. Mental-health care suffers from similar problems. The biological theory that really drives me nuts is the deep-roots theory of war. According to the theory, lethal group violence is in our genes. But the evidence is overwhelming that war was a cultural innovation. I hate the deep-roots theory not only because it’s wrong, but also because it encourages fatalism toward war. War is our most urgent problem.

Note: The above was written by John Horgan, director of the Center for Science Writings at the Stevens Institute of Technology. For more along these lines, see concise summaries of deeply revealing science corruption news articles from reliable major media sources.

Manufacturing jobs used to be a path to the middle class. But now many skilled, working Americans need some form of public assistance because their wages don’t pay for basic living expenses. Over 2 million supervised manufacturing workers, or about a third of the total, need food stamps, Medicaid, tax credits for the poor or other forms of publicly subsided assistance while they work on goods that can carry the tag “Made in the U.S.A.,” according to research of official government wage and welfare data released Tuesday by the University of California, Berkeley. The cost of these benefits to the U.S. taxpayer? From 2009 to 2013, federal and state governments subsidized the low manufacturing wages paid by the private sector to the tune of $10.2 million per year. “In decades past, production workers employed in manufacturing earned wages significantly higher than the U.S. average, but by 2013 the typical manufacturing production worker made 7.7 percent below the median wage for all occupations,” said the paper. The research aimed to extend an already well-established national debate on wages paid in the service industry, which are often juxtaposed to the factory work that lifted millions of Americans out of poverty for much of the 20th century. The research comes as U.S. workers overall are experiencing one of the lowest paces of wage growth on record.

Note: For more along these lines, see concise summaries of deeply revealing income inequality news articles from reliable major media sources.

We live in a time when people are less optimistic, more cynical and have lower expectations, in part because they see government and other institutions as ineffective and unresponsive. Of course the challenges we face today are as solvable as any problems we have confronted in the past. We as individuals still can make a difference. How? Well, one way is through our investments. We don’t have to wait for governments to take action. We can actually increase our influence over world events, and potentially have a greater impact (and feel a little less powerless) not just through civic participation, or voting, or supporting non-profits - all of which remain vitally important - but through our role as investors. Rather than investing in fossil fuel companies, you can invest in energy efficiency and renewable energy; clean water and pollution control; sustainable food and agriculture. The bottom line: As investors, we have more power than we realize. We can prod and pressure and cajole companies into doing the right thing. Unfortunately, too many of us fail to leverage this power. Investors are not powerless. We can move the needle. And ... it is both a moral imperative and an economic imperative that the needle be moved.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the corporate world.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.